Bracco Industria Chimica Spa, Milan, Clinical Research Directorate-Registration Service: communications with Bracco Delegation of Rome relating in particular to the modification of the moulds of the medicinal speciality "Penglobe" compr. 400 and 800 mg. and extemporaneous oral suspension for paediatric use of 60 and 100 ml.